Skip to main content

Cognito Therapeutics

Cambridge, United States

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

$105.0M raised
Mar 2026
Series C

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cognito Therapeutics

How much funding has Cognito Therapeutics raised?
Cognito Therapeutics has raised $105.0M in total funding. The most recent round was Series C. The last funding was announced in March 2026.
Who are Cognito Therapeutics's investors?
Cognito Therapeutics's investors include Apollo Health Ventures, IAG Capital Partners, OpAmp Capital, New Vintage Partners, Alzheimer's Drug Discovery Foundation.
Where is Cognito Therapeutics headquartered?
Cognito Therapeutics is headquartered in Cambridge, United States.
What does Cognito Therapeutics do?
Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.
What stage is Cognito Therapeutics at?
Cognito Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cognito Therapeutics — Funding & Investors." VCBacked, March 5, 2026, https://www.vcbacked.co/company/cognito-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Cognito Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cognito-therapeutics
Wikipedia (cite web)
{{cite web |title=Cognito Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cognito-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .